Myriad Genetics and Abbott Extend Collaboration
News Nov 23, 2005
Myriad Genetics, Inc. and Abbott have announced that they have extended their strategic alliance in pharmacogenetics.
The research collaboration will focus on identifying human genetic variation around drug targets in various stages of development.
Abbott will fund the research under this collaboration and Myriad will use its high-throughput sequencing technologies and proprietary mutation screening software to analyze samples from various populations to identify genetic polymorphisms, or differences in the DNA between individuals.
The results of this collaboration may help Abbott's drug discovery programs to develop drugs that will be effective for the widest range of patients.
"We are pleased to once again extend our successful relationship with Abbott in pharmacogenetics, an area in which Myriad can apply its proprietary technologies," said Peter Meldrum, President and Chief Executive Officer of Myriad Genetics, Inc.
"There is significant potential through this collaboration to develop new personalized medicine products in areas of important and growing healthcare needs."
Brian Spear, Director of genomic and proteomic technologies at Abbott said, "Myriad's technology and expertise are valuable to Abbott's drug discovery and development efforts in areas of significant unmet medical need."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018